
Multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR-TB) represent a critical antimicrobial resistance threat, significantly compromising treatment efficacy and overwhelming healthcare systems in endemic regions [1, 2]. Compared to drug-susceptible tuberculosis (TB) (more than 85%...

COVID-19 patients continue to experience neurological and mental health-related symptoms ranging from cognitive impairments, such as brain fog, to mental health disorders, including anxiety and depression, beyond the acute phase of SARS-CoV-2 infection [1, 2, 3, 4, 5, 6, 7, 8, 9–10]. This is known...

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, first emerged in Wuhan, China, in December 2019 and rapidly spread worldwide, leading to over 7 million deaths to date.1 SARS-CoV-2 is an enveloped, single-stranded, positive-sense RNA virus2, whose entry into...

Hepatitis B virus (HBV) infection remains a significant global health concern, with an estimated 296 million people chronically infected in 2019 [1]. HBV can be transmitted through transfusion, vertical transmission, sexual contact, and unsafe injections [2]. Therefore, rigorous blood screening for HBV...